Skip to content

Clinical trials

Hyperbilirubinemia, Neonatal trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperbilirubinemia, Neonatal Clear all

96 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20085
20092
20104
20112
20122
20137
20141
20155
20163
20172
20185
20197
20206
20214
20226
20236
202410
20259
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed55
Unknown status22
Recruiting7
Not yet recruiting5
Active, not recruiting2
Withdrawn2
Terminated1
Enrolling by invitation1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company5
Nanjing Medical University4
University of Aarhus4
University of Oxford3
Karabuk University2
National Taiwan University Hospital2
Rania Ali El-Farrash2
St. Olavs Hospital2
University of Minnesota2
University of Patras2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperbilirubinemia, Neonatal96
Jaundice, Neonatal29
Hyperbilirubinemia28
Jaundice10
Premature Birth6
Disease4
Glucosephosphate Dehydrogenase Deficiency3
Hemolysis3
Erythroblastosis, Fetal2
Anemia, Neonatal1

Trials

Showing 1 to 25 of 96. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.